Human epidermal growth factor receptor-2 (HER-2) positive breast cancer is characterized by its aggressive nature, rapid progression, resistance to conventional chemotherapy and poor prognosis (4, 5). The gene discussed is ERBB2; the disease is breast carcinoma.